https://www.selleckchem.com/pr....oducts/dl-alanine.ht
PSim device for therapeutic activities to increase strength, range of motion, resistance, and dexterity. All the participants will be assessed at baseline (week ; weeks 2, 4, and 8; and postintervention (week 1. The FEPSim study was launched in April 2020. This study is currently on hold because of the global COVID-19 pandemic. The recruitment process is expected to resume by September 2020, and the primary impact analysis is expected to be conducted by December 2020. This study will provide valuable information on the measuremen
Like
Comment
Share
